Prescription drug · BLA
Lyumjev (Insulin lispro-aabc) NDC 50090-7433
Insulin lispro 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-7433-0 | 5009074330050090743300 | 1 VIAL, MULTI-DOSE in 1 CARTON (50090-7433-0) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Nov 4, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lyumjev
- Generic name (nonproprietary)
- insulin lispro-aabc
- Active ingredients
- Insulin lispro — 100 [iU]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761109
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical/Ingredient)
- Identifiers
- Product ID 50090-7433_d1450e12-abc4-424d-be20-f1fc96a4a212SPL ID d1450e12-abc4-424d-be20-f1fc96a4a212SPL set ID 616daea1-0b79-4970-a141-6f99f2072f02RxCUI 2380231, 2380236UNII GFX7QIS1II
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N450090743300followed by a unit qualifier and the quantityPackage 50090-7433-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 50090-7433
- What is NDC 50090-7433?
- 50090-7433 is the product NDC for Lyumjev (insulin lispro-aabc), Insulin lispro 100 [iU]/mL injection, solution, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lyumjev (Insulin lispro-aabc).
- What is the active ingredient?
- Insulin lispro.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lyumjev?
- 2 other product NDCs are listed under this name. See all Lyumjev NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lyumjev products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7726 | 00002-7726-05 |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7728 | 00002-7728-01 |
Other NDCs under BLA 761109
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7726 |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Eli Lilly and Company | 0002-7728 |
| LYUMJEV Junior KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8351 |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8207 |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 200 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8228 |
| LYUMJEV Tempo Peninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8235 |